Top 10 Generic Drug Companies 2010

The following report is a listing of the top U.S. generic companies based on sales from Jan-Dec 2009. In recent years, Big Pharma has begun to look beyond brand-name drugs to the generics market. With the rising costs of healthcare, governments and payers alike are pushing for increased generics usage. And Big Pharma companies like Novartis and Pfizer are paying attention, striking deals with generics companies and even building units of their own.

FiercePharma's 2010 generic drugmakers report includes profiles of the top generics companies. Information included in this report was provided by IMS, a healthcare information and consulting company, and is based on sales of leading corporations in unbranded generics, MAT Dec. 2009.  Click here to see the companies. Report >>

1. Teva Pharmaceutical 
2. Mylan
3. Sandoz
4. Watson Pharmaceuticals
5. Greenstone

6. Par Pharma
7. Hospira
8. Apotex
9. Mallinckrodt
10. Dr. Reddy's


Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

The agency has granted Tecentriq a priority review in previously untreated NSCLC, setting up the Roche drug for an approval decision by June 19.

Warren Buffett's Berkshire Hathaway has built a $192 million stake in Biogen, a risky investment considering aducanumab's uncertain future.